[TimAlerts] RGLS

[TimAlerts] RGLS Regulus announces grant of patents covering microRNA therapeutics Regulus Therapeutics announced that the U.S. Patent and Trademark Office, or USPTO, has granted patents related to Regulus' most advanced microRNA therapeutics, RG-101, the company's wholly-owned, GalNAc-conjugated anti-miR-122 being developed to treat HCV, and RG-012, an anti-miR-21 being developed to treat Alport syndrome.

[TimAlerts] RGLS nhd

[TimAlerts] RGLS breaking out over multi-month resistance

[TimAlerts] RGLS spike

[TimChallenge] SS RGLS $9.21 covered $8.60 into the panic

[TimAlerts] RGLS nice chart and b/o

[TimAlerts] RGLS nhod

[TimAlerts] RGLS climbing

[TimAlerts] RGLS ripper. PR after hours